The co-founder of Beam Therapeutics and Prime Medicine has formed a new biotech that plans to reprogram a group of protein-cutting enzymes to treat disease.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,